Iberoamerican Nutrition Foundation -FINUT-, Granada, Spain.
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Adv Nutr. 2019 May 1;10(suppl_2):S251-S271. doi: 10.1093/advances/nmz001.
There is insufficient evidence on the role of functional fortified dairy products in improving health and in preventing risk factors associated with noncommunicable chronic diseases. This systematic review was conducted to summarize effects of the consumption of fortified dairy products on biomarkers of cardiometabolic risk. MEDLINE and SCOPUS databases were used to perform searches to include studies published up to 30 April 2018. Randomized clinical trials with human subjects consuming dairy products fortified with phytosterols, FAs, vitamins or minerals and relating this consumption with cardiometabolic health were included in this review. Risk of bias assessment according to Cochrane guidelines was performed to determine the quality of the trials. Forty-one studies were finally selected for this synthesis; the selected studies tested dairy products fortified with the following nutrients and bioactive components: phytosterols (n = 31), FAs (n = 8), and vitamin D (n = 2). We found that the consumption of phytosterol-fortified dairy, led to an overall LDL cholesterol reduction of -0.36 (-0.41, -0.31) mmol/L, P < 0.001; this decrease was mainly related to the dosage. Likewise, consumption of ω-3 FA-fortified dairy products resulted in a plasma LDL cholesterol reduction of -0.18 (-0.27, -0.09) mmol/L as well as a decrease of -0.18 (-0.32, -0.05) mmol/L in triacylglycerols (TG). Performing meta-analyses of the consumption of dairy products fortified with vitamin D or FAs other than ω-3 FAs and biomarkers of cardiometabolic risk was not possible because of the few available publications. Our results indicate that consumption of dairy products fortified with phytosterols and ω-3 FAs can lead to a reduction of LDL cholesterol and consumption of fortified dairy products fortified with ω-3 FAs can reduce TG concentration. However, more studies with homogeneous designs are needed to determine the advantages of using dairy products as fortification vehicles to prevent cardiometabolic risk.
关于功能性强化乳制品在改善健康和预防与非传染性慢性疾病相关的风险因素方面的作用,目前尚无足够的证据。本系统评价旨在总结强化乳制品消费对心血管代谢风险生物标志物的影响。使用 MEDLINE 和 SCOPUS 数据库进行检索,以纳入截至 2018 年 4 月 30 日发表的研究。本综述纳入了随机临床试验,这些试验涉及人类受试者消费强化了植物固醇、脂肪酸、维生素或矿物质的乳制品,并将这种消费与心血管代谢健康联系起来。根据 Cochrane 指南进行了偏倚风险评估,以确定试验的质量。最终有 41 项研究被纳入本综述;所选研究测试了强化了以下营养素和生物活性成分的乳制品:植物固醇(n=31)、脂肪酸(n=8)和维生素 D(n=2)。我们发现,消费强化植物固醇的乳制品可使 LDL 胆固醇总体降低-0.36(-0.41,-0.31)mmol/L,P<0.001;这种降低主要与剂量有关。同样,消费强化 ω-3 脂肪酸的乳制品可使 LDL 胆固醇降低-0.18(-0.27,-0.09)mmol/L,使三酰甘油(TG)降低-0.18(-0.32,-0.05)mmol/L。由于可获得的出版物很少,因此无法对强化了维生素 D 或除 ω-3 脂肪酸以外的其他脂肪酸的乳制品的消费进行 meta 分析以评估其对心血管代谢风险生物标志物的影响。我们的结果表明,消费强化植物固醇和 ω-3 脂肪酸的乳制品可降低 LDL 胆固醇,而消费强化 ω-3 脂肪酸的乳制品可降低 TG 浓度。但是,需要进行更多设计一致的研究来确定使用乳制品作为强化载体来预防心血管代谢风险的优势。